Cost-effectiveness thresholds play a vital role in healthcare decision-making, helping to ensure that NHS resources are used ...

New analysis presented by the company, together with an improved discount to the price of vamorolone, mean that NICE can now ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

A list of downloadable documents created during development.

To declare any new board interests and executive team interests, and consider any conflicts of interest specific to the meeting. Minutes of the last board meeting (Word) To approve the minutes of the ...

Suggested remit: To appraise the clinical and cost effectiveness of glycopyrronium bromide cream within its marketing authorisation for treating severe primary axillary hyperhidrosis.

Tirzepatide has been shown in clinical trials to be more effective than diet and exercise support alone, and when compared ...

Around a quarter of a million people living with obesity will be offered the weight loss drug tirzepatide, alongside a reduced-calorie diet and increased physical activity, over the next three years, ...

Following on from advice received from the company, NICE has decided to suspend this appraisal from its work programme whilst the company confirm their regulatory filing plans ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...